MAZE

Maze TherapeuticsNASDAQ · StockExchangeNASDAQ

$36.72+1.29 (+3.64%)US pre-market · opens in 4h 18m

At close

Free account:WatchlistPrice and earnings alertsTrade TalkNo trading account needed

Daily move+3.6%vs prev close $35.43

VolatilityHighATR $1.51 · 4.1%

Gap %0.0%Open vs prev close

52-week position47%of range $21.98–$53.60

Loading chart…

Why is MAZE moving?

AI summary · updated 04:01 ET

Maze Therapeutics rose 3.64% as of the last close, with the move mostly company-specific. No news, earnings, or analyst story was provided to explain the change, while the broader market contributed 1.32 percentage points and specific factors 2.32 percentage points.

marketBroader market added 1.32 pointsNoteNo story provided for move

Written by AI from 0 linked sources and refreshed as news lands. It can contain mistakes and is not investment advice.

Part of

Collections that include MAZE

ExchangeNASDAQ-listed+2.5% today

Investor holdings

Held by 4 of 50 tracked investors13F · Q2 2026 · filed by Aug 14

2added4trimmed or sold

Citadel AdvisorsKen Griffin · Multi-strategy fund0.0%$25MAdded +10%Two Sigma InvestmentsJohn Overdeck & David Siegel · Quant fund0.0%$6MAdded +1118%AQR Capital ManagementCliff Asness · Quant fund0.0%$810KTrimmed −3%D. E. ShawDavid E. Shaw · Quant fund0.0%$359KTrimmed −74%US long positions only · filings lag the quarter end by up to 45 days · SEC EDGAR 13F · All tracked investors

Key stats

Stock

Open / Prev close: $35.41 / $35.43
Day range: $35.41 – $37.23
52-week range: $21.98 – $53.60
Volume: 43.23K
ATR (14): $1.51 · 4.1% · High
Gap %: 0.0%

SEC filings

All filings

Nov 9, 2026Quarterly report filedQuarterly report · SEC EDGAR10-Q Nov 9, 2026Reported results of operationsMaterial event · SEC EDGAR8-K Nov 4, 2026Insider trade reportedInsider trade · SEC EDGARForm 4 Oct 30, 2026Insider trade reportedInsider trade · SEC EDGARForm 4 Oct 16, 2026Entered a material agreement; Sold unregistered sharesMaterial event · SEC EDGAR8-K Aug 17, 2026Director or officer change; Regulation FD disclosureMaterial event · SEC EDGAR8-K

About Maze Therapeutics

Maze Therapeutics is listed on NASDAQ and belongs to the null industry in the null sector.

Exchange: NASDAQ

MAZE FAQ

When is MAZE’s next earnings report?

Mar 22, 2027. Analysts expect EPS of $-0.83.

Why is MAZE stock moving today?

Maze Therapeutics rose 3.64% as of the last close, with the move mostly company-specific.

How volatile is MAZE?

MAZE’s average true range over 14 days is $1.51, 4.1% of its price. That puts it in our high volatility class.

Best match for stocks

Put your MAZE edge to the test with Trade The Pool

Stock-specific funded accounts. Trade US equities like MAZE with firm capital and keep a share of the profits.